Q1 2023 Natco Pharma Ltd Earnings Call Transcript

Aug 10, 2022 / 05:30AM GMT
Operator

Good morning, ladies and gentlemen, and welcome to the Q1 FY '23 Earnings Conference Call of NATCO Pharma Limited, hosted by Edelweiss Securities.

(Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Kunal Randeria from Edelweiss Securities. Thank you.

And over to you, sir.

Kunal Randeria - Edelweiss Securities Limited, Research Division - Research Analyst

Thank you, Michel. Good morning and welcome, everyone. On behalf of Edelweiss Securities, I welcome you all to NATCO Pharma's Q1 FY '23 Earnings Conference Call.

We have with us Mr. Rajeev Nannapaneni, Director and Chief Executive Officer of NATCO Pharma; and Mr. Rajesh Chebiyam, Executive Vice President, Crop Health Sciences. I will hand over the call to Rajesh for his opening remarks.

Over to you, Rajesh.

Rajesh Chebiyam - NATCO Pharma Limited - EVP of Crop Health Sciences

Thank you, Kunal. Again, good morning, everyone. And welcome to NATCO's conference

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot